FI853307A7 - Ihmisen lymfoblastoidi -leukosyyttihydridi-interferoneja. - Google Patents

Ihmisen lymfoblastoidi -leukosyyttihydridi-interferoneja. Download PDF

Info

Publication number
FI853307A7
FI853307A7 FI853307A FI853307A FI853307A7 FI 853307 A7 FI853307 A7 FI 853307A7 FI 853307 A FI853307 A FI 853307A FI 853307 A FI853307 A FI 853307A FI 853307 A7 FI853307 A7 FI 853307A7
Authority
FI
Finland
Prior art keywords
interferons
leukocyte
hydride
human lymphoblastoid
lymphoblastoid
Prior art date
Application number
FI853307A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI853307L (fi
FI853307A0 (fi
Inventor
Marvin Harry Caruthers
Moshe Leitner
Yitzhak Stabinsky
Michael Leineweber
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/646,557 external-priority patent/US4734491A/en
Priority claimed from US06/646,866 external-priority patent/US4716217A/en
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of FI853307A0 publication Critical patent/FI853307A0/fi
Publication of FI853307L publication Critical patent/FI853307L/fi
Publication of FI853307A7 publication Critical patent/FI853307A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI853307A 1984-08-31 1985-08-29 Ihmisen lymfoblastoidi -leukosyyttihydridi-interferoneja. FI853307A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/646,557 US4734491A (en) 1984-08-31 1984-08-31 DNA sequences encoding hybrid lymphoblastoid-leukocyte human interferons
US06/646,866 US4716217A (en) 1984-08-31 1984-08-31 Hybrid lymphoblastoid-leukocyte human interferons

Publications (3)

Publication Number Publication Date
FI853307A0 FI853307A0 (fi) 1985-08-29
FI853307L FI853307L (fi) 1986-03-01
FI853307A7 true FI853307A7 (fi) 1986-03-01

Family

ID=27094957

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853307A FI853307A7 (fi) 1984-08-31 1985-08-29 Ihmisen lymfoblastoidi -leukosyyttihydridi-interferoneja.

Country Status (9)

Country Link
EP (1) EP0173935A1 (en:Method)
KR (1) KR870002262A (en:Method)
DK (1) DK397885A (en:Method)
ES (1) ES8700694A1 (en:Method)
FI (1) FI853307A7 (en:Method)
GR (1) GR852100B (en:Method)
IL (1) IL76258A0 (en:Method)
NO (1) NO853433L (en:Method)
PT (1) PT81057B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
US4885166A (en) * 1985-06-11 1989-12-05 Ciba-Geigy Corporation Hybrid interferons
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76

Also Published As

Publication number Publication date
ES8700694A1 (es) 1986-10-16
PT81057A (en) 1985-09-01
KR870002262A (ko) 1987-03-30
DK397885A (da) 1986-03-01
FI853307L (fi) 1986-03-01
GR852100B (en:Method) 1986-01-02
FI853307A0 (fi) 1985-08-29
NO853433L (no) 1986-03-03
ES546525A0 (es) 1986-10-16
PT81057B (en) 1987-04-06
IL76258A0 (en) 1986-01-31
EP0173935A1 (en) 1986-03-12
DK397885D0 (da) 1985-08-30

Similar Documents

Publication Publication Date Title
IT8124967A0 (it) Interferoni di leucociti umani ibridi.
NO862637D0 (no) Integrert ryggstykke.
FI874819L (fi) Human rekombinant endotelcell vaextfaktor.
DE3672006D1 (de) Integrierter ram-speicher.
FI893872A0 (fi) Human interleukin-3 och dess mutein.
TR25164A (tr) INTEKTISID ÖZELLIKTE N'-SüBSTITüENTLI-N,N-DIACIL- HIDRAZINLER
FI850946L (fi) Medicinska plaoster.
DE3674290D1 (de) Maehdrescher.
DE3581730D1 (de) Menschlicher tumornekrosisfaktor.
ES510718A0 (es) "cosechadora perfeccionada".
IT8521468A0 (it) Procedimento per ottenere interferon leucocitario alfa-2dell'uomo.
FI864552L (fi) Human-lysozym.
FI853249A0 (fi) Cdna-kloner foer human erytropoietin.
NO159573C (no) Blodpose.
DK256385D0 (da) Interferonpraeparat
ES292502Y (es) Gabardina perfeccionada.
DE3677282D1 (de) Maehdrescher.
GB8521312D0 (en) Alpha interferons
ATE92334T1 (de) Stabilisierte leukocyten-interferone.
FI860780A7 (fi) Ortopedinen liivi.
FI863187L (fi) Bakteriostatiska hemodialyskoncentrat.
FI853307A7 (fi) Ihmisen lymfoblastoidi -leukosyyttihydridi-interferoneja.
ZA856644B (en) Hybrid lymphoblastoid-leukocyte human interferons
FI862738A7 (fi) Menetelmä ihmisleukosyyttien interferonin valmistamiseksi.
DE3586574D1 (de) Menschliches gamma-interferon.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: UNIVERSITY PATENTS, INC.